Aurobindo Pharma Ltd

Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are enclosing herewith the schedule of Earnings Call to be held on February 10 2023 at 8:30 AM (IST) on Unaudited Financial Results of the Company for the third quarter and nine months period ended December 31 2022.